Overview Bleeding Pattern Study Status: Completed Trial end date: 2005-02-01 Target enrollment: Participant gender: Summary The aim of this study is to evaluate bleeding pattern, cycle control, contraceptive efficacy and safety of this oral contraceptive in two different regimens of intake. Phase: Phase 3 Details Lead Sponsor: BayerTreatments: Contraceptive AgentsContraceptives, OralDienogestNandrolone